The demand for more efficient and agile downstream purification processes for diversified therapeutic antibody pipelines requires the development of new strategies and technologies.
Watch this webinar to learn from industry experts about:
- Emerging technologies and approaches for intensifying mAb purification
- Strategies for a diversified antibody pipeline including bispecific antibodies, fragments, and ADC
- How process development can improve process robustness, reduce risk, and speed time to market